MabThera/Rituxan

Rituximab · Roche

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for MabThera/Rituxan, covering 2014-11-04 to 2017-03-22. Get the full timeline:

Most recent: Clinical Trial Update: An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

See pricing